S1 Biopharma


S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction and hypoactive sexual desire disorder (HSDD) in both women and men. The company’s non-hormonal therapies work uniquely by restoring the natural balance of neurotransmitters in the brain.

Industries

Employees

11-50

Links


Org chart

Collapse
John F. Kaufmann
Chief Financial Officer, Co-founder

Board & advisors

Gregg A. Lapointe
Board Member
Anita H. Clayton
Medical Advisory Board Member
Robert Taylor Segraves
Medical Advisory Board Member
Molly A. Katz
Medical Advisory Board Member
Leonard R. Derogatis
Medical Advisory Board Member
Cindy M. Meston
Medical Advisory Board Member


Offices